Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe thigh is one of three licensed injection sites for Mounjaro (tirzepatide), and for many people it becomes their preferred spot once they've done it a few times. Before your first self-injection, watching a clear, step-by-step video of the technique can make the whole thing feel far less daunting. This page walks you through exactly what to do, what to check beforehand, and what the NHS tirzepatide guidance says about safe injection practice — so you arrive at that first injection feeling prepared rather than anxious. Mounjaro is a prescription-only medicine; a prescriber assesses suitability before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
That moment before a first self-injection is genuinely nerve-wracking for most people, and it's worth saying that plainly rather than glossing over it. The good news is that the Mounjaro KwikPen is designed around exactly this situation, its mechanism means there is no exposed needle to see before or after use, which removes one of the biggest sources of anxiety straight away.
Before you do anything, wash your hands thoroughly with soap and water. Take the pen from the fridge and set it on the counter; letting it sit at room temperature for around 30 minutes makes the injection more comfortable, though the exact storage and temperature window your pen must stay within is set out in the Patient Information Leaflet that comes with your medicine, follow that, not any figure you read online. While you wait, look at the outer, fleshy part of one thigh: that is your target area. Avoid the inner thigh, the back of the thigh, and anywhere within a few centimetres of the knee. Our guide to the Mounjaro thigh injection site covers the anatomy in more detail if you want to mark out the zone visually before you begin.
Clean the skin with an alcohol swab and allow it to dry fully, around 10 seconds. Wet skin stings more and can affect absorption.
A good how-to-inject-Mounjaro-in-thigh video will show three things clearly: the cap removal, the pen placement, and the slow button press. Here is what you are watching for.
Remove the base cap only, the one covering the needle end. Do not remove the clear cap at the top. Hold the pen so the clear window faces you; you should see the medicine inside. Press the pen flat against the outer thigh (you do not need to pinch the skin unless you have very little subcutaneous tissue, your prescriber can advise). Press the button slowly and hold it down. Keep the pen in place while you count to ten after the click; this ensures the full dose is delivered. When you lift the pen away, the needle retracts automatically. You will not see it.
If you find the angle awkward, sitting on the edge of a chair with the leg relaxed can help, the muscle is less tense and the site easier to reach. Our full Mounjaro injection overview covers sitting versus standing positions, and if you want a visual reference specifically for the thigh technique, the tirzepatide thigh injection video page goes through the KwikPen motion frame by frame.
After each injection, discard the used pen in a lidded sharps container, never in the household bin or recycling.
Rotating your injection site each week matters more than many people realise. Using the same spot repeatedly leads to a build-up of scar tissue under the skin (lipohypertrophy), which slows absorption and makes the medicine less predictable. A simple rhythm helps: left thigh one week, right thigh the next, then the abdomen, and so on. The Mounjaro SmPC on the electronic Medicines Compendium gives the full rotation guidance your prescriber follows.
Mild injection-site reactions (a little redness, itching or a temporary lump) are normal and typically resolve within a day or two. If you notice persistent swelling, warmth, or the skin looks infected, contact your prescriber or GP.
The side effects most commonly associated with Mounjaro are gastrointestinal: nausea, loose stools, constipation, or indigestion, particularly in the first few weeks of a new dose. These are not related to where you inject, but to how the medicine works on gut receptors. Drinking plenty of water and eating smaller meals can help your system adjust. Severe or persistent stomach pain that spreads toward the back needs prompt medical attention, tell a healthcare professional straight away, as this can occasionally signal a problem with the pancreas. The MHRA included this warning in its January 2026 Drug Safety Update on GLP-1 medicines.
Mounjaro is not the right medicine for everyone. It is not licensed for use during pregnancy, while breastfeeding, or for those actively trying to conceive, and it is not approved for under-18s. Your prescriber goes through your full medical history before treatment starts. If you are curious about whether you might be eligible, you can check your eligibility with our prescribers through a free consultation, reviewed the same day by a named, GPhC-registered clinician.
For more on what to expect across the full injection process, the Mounjaro injection video guide covers all three sites together, or you can read about the thigh-specific technique and tips in prose form. Questions about Mounjaro as a treatment more broadly are answered on our Mounjaro treatment page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.